Skip to search formSkip to main contentSkip to account menu

blonanserin

Known as: 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

AD 5423lonasen

Broader (2)

PiperazinesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
Objective This study was performed to investigate the efficacy and tolerability of blonanserin in schizophrenic patients who were… 
2018
2018
Synthesis of indole–cycloalkyl[b]pyridine hybrids via a four-component six-step tandem process
The one-pot four-component reaction of 3-(1H-indol-3-yl)-3-oxopropanenitriles, aromatic aldehydes, cycloalkanones and ammonium… 
2016
2016
Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.
INTRODUCTION Many psychiatric disorders show signs and symptoms of anxiety and depression. A drug with both, effects and lesser… 
2014
2014
Retracted: Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial
The above article from Psychiatry and Clinical Neurosciences, first published on 6 July 2014 in Wiley Online Library (www… 
2014
2014
Simple and Sensitive Analysis of Blonanserin and Blonanserin C in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry and Its Application
A highly sensitive, simple, and rapid liquid chromatography tandem mass spectrometry method to simultaneously determine… 
2012
2012
Blonanserin in management of Schizophrenia
Schizophrenia was the seventh leading cause of life years lived with disability worldwide in 2000, according to WHO estimates.1… 
2012
2012
Retracted: Effect of blonanserin on cognitive function in antipsychotic‐naïve first‐episode schizophrenia
The purpose of this study was to evaluate the effects of blonanserin, a novel antipsychotic, on cognitive function in first… 
2010
2010
Simple analysis of blonanserin, a novel antipsychotic agent, in human plasma by GC-MS
Blonanserin is a novel antipsychotic agent having dopamine D2 and serotonin 5-HT2A receptor antagonist properties. In this… 
2010
2010
Sensitive Analysis of Blonanserin, a Novel Antipsychotic Agent, in Human Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
A rapid and sensitive method for analysis of blonanserin in human plasma by ultra-performance liquid chromatography– tandem mass… 
2008
2008
新規抗精神病薬ブロナンセリン（ロナセン®）の薬理作用と臨床効果
ブロナンセリン（ロナセン®）は大日本住友製薬株式会社で創製された新規抗精神病薬であり，ドパミンD2およびセロトニン5-HT2A受容体に対する強い遮断作用により抗精神病作用を発現する．リスペリドンやオランザピンといった第二世代抗精神病薬の多くはセロトニン5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)